Prevalence of complementary medicine use in a phase 1 clinical trials program: The MD Anderson Cancer Center Experience

Cancer

Volumn 117, Issue 22, 2011, Pages 5142-5150

  Naing, Aung ^a   Stephen, Saneese K ^a   Frenkel, Moshe ^a   Chandhasin, Chandtip ^a   Hong, David S ^a   Lei, Xiudong ^a   Falchook, Gerald ^a   Wheler, Jennifer J ^a   Fu, Siqing ^a   Kurzrock, Razelle ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

alternative medicine; complementary medicine; phase 1 clinical trials

Indexed keywords

VITAMIN;

ACCESS TO INFORMATION; ACUPUNCTURE; ADULT; AGE; ALTERNATIVE MEDICINE; ARTICLE; CANCER THERAPY; COST; DOCTOR PATIENT RELATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FAMILY; FEMALE; FRIEND; GENDER BIAS; HEALTH CARE UTILIZATION; HERBAL MEDICINE; HUMAN; HYPNOSIS; INCOME; INTERNET; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MASSAGE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE; RACE; RELIGION; SAFETY;

CLINICAL TRIALS, PHASE I AS TOPIC; COMPLEMENTARY THERAPIES; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 80555150818     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26164     Document Type: Article

References (19)

1. Accessed April 14, 2011.
2. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004; 22: 671-677. (Pubitemid 41095070)
3. Ernst E,. The role of complementary and alternative medicine. Lancet Oncol. 2000; 321: 176-180.
4. Richardson MA, Sanders T, Palmer JL, et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000; 18: 2505-2514. (Pubitemid 30432515)
5. Wilkinson S, Farrelly S, Low J, et al. The use of complementary therapy by men with prostate cancer in the UK. Eur J Cancer Care (Engl). 2008; 17: 492-499.
6. Dy GK, Bekele L, Hanson LJ, et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. J Clin Oncol. 2004; 22: 4810-4815.
7. Hlubocky FJ, Ratain MJ, Wen M, et al. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007; 25: 548-554. (Pubitemid 350002962)
8. Gupta G, Lis CG, Birdsall TC, et al. The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer care. Support Care Cancer. 2005; 13: 912-919. (Pubitemid 41502251)
9. DiPaola RS, Zhang H, Lambert GH, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med. 1998; 339: 785-791. (Pubitemid 28447451)
10. Labriola D, Livingston R,. Possible interactions between dietary antioxidants and chemotherapy. Oncology. 1999; 19: 1003-1008.
11. Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002; 137: 889-903. (Pubitemid 35416625)
12. Frenkel M, Cohen L,. Incorporating complementary and integrative medicine in a comprehensive cancer center. Hematol Oncol Clin North Am. 2008; 22: 727-736. (Pubitemid 351970210)
13. Naing A, Aaron J, Kurzrock R,. Juice plus or toxicity plus. Am J Med. 2010; 123: e1-2.
14. Stickel F, Patsenker E, Schuppan D,. Herbal hepatotoxicity. J Hepatol. 2005; 43: 901-910. (Pubitemid 41414517)
15. Chitturi S, Farrell GC,. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol. 2000; 15: 1093-1099.
16. De Smet PA,. Herbal remedies. N Engl J Med. 2002; 347: 2046-2056. (Pubitemid 35461662)
17. Frenkel M,. Clinical consultation, a personal perspective: components of a successful integrative medicine clinical consultation. J Soc Integr Oncol. 2008; 6: 129-133.
18. Frenkel M, Ben-Arye E, Baldwin CD, et al. Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J. 2005; 98: 289-294. (Pubitemid 40381706)
19. Verhoef MJ, Boon HS, Page SA,. Talking to cancer patients about complementary therapies: is it the physician's responsibility? Curr Oncol. 2008; 15: s88-s93.